People

Search Language

日本語 / Japanese | Use language selector above (below, on mobile) to search additional languages
  • Selected filters
  • x(New York)

255 items matching filters

Search Results

Erica Rosenthal Deputy General Counsel

New York

Erica draws on deep experience in legal ethics and litigation. She served as Staff Attorney with the New York State Commission on Judicial Conduct, where she investigated and prosecuted judges for ethical violations. Prior to joining Orrick, she was Deputy General Counsel at Foley & Lardner, advising the firm on complex legal ethics, regulatory, compliance, procurement, and other professional responsibility and risk management issues. She began her private practice career as a litigator at Morvillo, Abramowitz and Gibson, Dunn.

Erica clerked for the Hon. Peter K. Leisure of the U.S. District Court for the Southern District of New York and was an Adjunct Professor of Legal Writing & Research at Fordham University School of Law.

Ari Roytenberg シニア・アソシエイト

New York

Ari's experience includes supervising cases through all phases of litigation, from pre-litigation strategy through appeal. Most recently, Ari served as lead counsel to an aerospace defense company in litigation that began in New York State court and continued through a six-month trial in bankruptcy court in connection with a $1.3 billion restructuring transaction. His courtroom advocacy, briefing strategies, and fact and expert depositions have helped secure favorable outcomes to a number of clients involved in high-stakes disputes.

Before joining Orrick, Ari was an associate with Quinn Emanuel Urquhart & Sullivan LLP and served as a law clerk to Judge Richard M. Berman on the United States District Court for the Southern District of New York.

450076

Practice:

  • 知的財産
  • Patents
  • Life Sciences & HealthTech
  • Supreme Court & Appellate

Irena Royzman, Ph.D. パートナー

New York

With a Ph.D. in biology from MIT and the Whitehead Institute, where she was a NSF fellow, Irena represents plaintiffs and defendants in their most complex pharmaceutical and biotech patent cases. Over the last 20 years, pharmaceutical and biotechnology innovators have relied on Irena again and again for cases involving small molecules, biologics, recombinant DNA technology, gene therapy, gene editing, manufacturing processes, formulations and drug-eluting medical devices, including numerous multi-billion dollar cases involving many of the world’s best-selling drugs.

Irena has significant experience in litigation under the Hatch-Waxman Act (ANDA and 505(b)(2) actions) and the Biologics Price Competition and Innovation Act (BPCIA), as well as inter partes review (IPR) proceedings, license disputes and matters with parallel ex-U.S. litigation and proceedings in foreign patent offices. Irena also helps life sciences companies and organizations develop the law in the most important cases for the biopharma industry. She has been principal counsel on numerous amicus briefs to the United States Supreme Court and the Federal Circuit in key biopharma cases.

For plaintiffs, Irena has successfully defended generic challenges to patents protecting blockbuster medical therapies, including multi-billion dollar cancer, antiviral, diabetes and anti-psychotic drugs, including recently obtaining attorneys’ fees in a hard-fought ANDA action. She also represents innovators in biosimilar litigation from its outset, including in some of the first cases under the BPCIA involving antibodies. Irena also represents clients in innovator vs innovator disputes. For defendants, she defeated a $530 million claim of patent infringement of a competitor’s biotech patent, obtaining dismissal of all claims and discovery sanctions against the patent owner. In another high-stakes case, she obtained summary judgment of noninfringement and exclusion of plaintiff’s experts under Daubert as well as a full award of attorneys’ fees. A registered patent attorney, Irena also handles inter partes review (IPR) proceedings. For patent owners, she has obtained denial of IPR for patents protecting blockbuster drugs and has leveraged IPR for defendants to obtain freedom to operate.

Irena also coordinates U.S. proceedings with parallel ex-U.S. litigation and proceedings in foreign patent offices, recently obtaining freedom to operate for a biotech innovator’s gene therapy. She provides strategic counseling in biologics and pharmaceuticals and advises clients on their IP portfolios and transactions. Irena also represents clients in high-stakes license disputes involving biotech patents, and, in a dispute concerning the use of a recombinant protein as an enzyme replacement therapy, obtained one of the largest settlement awards over the life of the contract.

Chambers USA has recognized Irena as a leading lawyer in intellectual property, where clients have described her as “excellent,” “knowledgeable, aggressive,” “knows the science forward and backward” and “an incredibly smart lawyer.” Benchmark Litigation named her one of the “Top 250 Women in Litigation” for the last eight years and a litigation star in intellectual property. Irena was also named to the Crain’s New York Business list of “Notable Women in Law.” She is also recognized as a leading lawyer by Legal 500. Irena writes and lectures widely on biopharma patent issues and biosimilar litigation. Irena also is frequently quoted on patent-related issues, including in the Washington Post, Financial Times, Nature Biotechnology, Bloomberg and Pink Sheet.

740

Practice:

  • Supreme Court & Appellate

Daniel A. Rubens パートナー

New York

Danny's practice focuses on appellate litigation. He has led the drafting on dozens of appellate briefs, and regularly argues appeals in state and federal courts. Danny has extensive trial litigation experience as well, with an emphasis on dispositive motions, preserving appellate issues, and developing creative legal strategies.

Danny’s work has covered a wide range of subject areas, including securities, bankruptcy, intellectual property, arbitration, class actions, and criminal law. He has a deep understanding of appeals and critical motions in financial services litigation, and in recent years has played a key role in representing financial institutions in major RMBS cases brought by trustees, investors, and monoline insurers. His financial services clients include Credit Suisse, Goldman Sachs, Mr. Cooper, and Ocwen. He also represents leading technology companies in precedent-setting cases involving antitrust law and ballot initiatives, as well as other complex commercial litigation.  In addition, Danny is an experienced bankruptcy litigator, having represented various debtors and creditors in fraudulent transfer cases and other contested insolvency-related matters involving U.S. and foreign law.

Danny is a member of the Second Circuit's pro bono panel and maintains an active pro bono practice focusing on criminal, immigration, racial justice, and LGBTQ+ rights matters in the Supreme Court and other appellate courts. He was recently recognized by the National LGBTQ+ Bar Association as a “Best LGBTQ+ Lawyer Under 40,” by the New York Law Journal as a Rising Star, and by LawDragon in its inaugural 500 X – The Next Generation listing.  As part of his commitment to diversity, equity, and inclusion, Danny serves as a mentor for The Appellate Project, an organization focused on empowering law students of color to thrive in the appellate field. He has also served as an Orrick ambassador for the Move The Needle Fund, a collaborative effort designed by Diversity Lab to create a more diverse and inclusive legal profession.

Before joining Orrick, Danny served as a law clerk to U.S. Supreme Court Justice Ruth Bader Ginsburg, Judge Robert A. Katzmann of the U.S. Court of Appeals for the Second Circuit, and Judge Jed S. Rakoff of the U.S. District Court for the Southern District of New York. Following his clerkships, he was selected to represent the American Inns of Court as a Temple Bar Scholar in London.

740

Practice:

  • Mergers and Acquisitions
  • Capital Markets
  • ラテン・アメリカ
  • Life Sciences & HealthTech

David M. Ruff パートナー

New York

David advises private equity funds, their portfolio companies and a broad range of public and private technology, energy and life sciences companies in domestic and cross-border M&A, minority and majority investments, joint ventures and other complex transactions.
740

Practice:

  • Finance Sector
  • White Collar, Investigations, Securities Litigation & Compliance
  • 証券訴訟、集団代表訴訟および株主代表訴訟
  • Financial Services Litigation
  • 政府による調査および強制措置
  • 内部調査

Paul F. Rugani パートナー

オレンジ・カウンティ; New York; シアトル

Legal 500 touts Paul as a recommended attorney for Securities Litigation, observing that he is “among the most creative and strategic lawyers” who always has “an eye on the end game.”  Paul achieved American Lawyer Litigator of the Week recognition as part of a team that achieved a ground-breaking New York Court of Appeals victory that substantially reduced financial exposure in RMBS repurchase litigation.

Leader of Orrick's Securities Litigation practice and deputy leader of the Firm's Financial Services Litigation practice, Paul has extensive experience representing clients in securities class actions, shareholder derivative lawsuits, commercial contractual disputes and other complex litigation matters at both the trial and appellate levels, as well as in connection with internal, government and regulatory investigations. Paul also counsels domestic and foreign accounting firms on matters related to state CPA licensing and state board regulation.

740

Practice:

  • Employment Law & Litigation
  • Compensation & Benefits

Chanani Sandler オブ・カウンセル

New York

Chanani advises multinational companies across all industry lines on a variety of employment-related matters and implementation of global equity compensation programs. He globally manages large multi-country and large multi-function HR projects.

From an employment law perspective, Chanani advises his clients on a wide range of employment-related matters outside the United States, including global/local offer letters and employment contracts, rollout of HR policies and employee handbooks as well as termination and settlement agreements. His work also covers advising clients hiring, HR data privacy compliance, discrimination risks, as well as performance management and terminations. He also works with his clients to consider the employment-related impact of, and undertake due diligence for, cross-border corporate transactions, including mergers and acquisitions, spin-offs, and IPOs.

Chanani also counsels his clients on how to effectively design, implement, communicate and administer equity-based compensation programs and other long-term incentive awards to their employees and other service providers worldwide. His work covers securities law, foreign exchange, employment, tax and other compliance requirements related to these programs. He also provides services in the areas of corporate tax planning, cross-border tax planning, payroll support and employee education with respect to global equity programs, including in the context of corporate transactions.

He has presented at industry educational forums, such as the National Association of Stock Plan Professionals (NASPP) and Global Equity Organization (GEO), on topics related to tax compliance as well as effective design, implementation and administration of global equity-based awards and other long-term incentive plans.

740

Practice:

  • Finance Sector
  • Structured Finance
  • Asset‐Backed Securities
  • Banking & Finance
  • Residential Mortgage‐Backed Securities
  • Public Finance
  • 歳入担保債ファイナンス
  • Fintech

Leah Sanzari パートナー

New York

Having long represented issuers of asset backed securities and drawing on that experience, today, in addition to issuer representation, Leah’s practice includes a significant focus on investor-side representation. Leah represents both issuers and investors in complex deals of first impression and brings a unique, creative approach to securitization transactions, with deal execution as top priority.

Leah and her team have pioneered proved developed producing (PDP) oil & gas wellbore securitizations, acting as investor counsel on substantially all of the transactions that have been executed in the market to date. Also a pioneer of the C-PACE market, Leah regularly advises the top C-PACE issuers in both 144A and 4(a)(2) transactions, including Greenwork Lending’s first Rule 144A Commercial PACE securitization which was recognized as the 2022 Esoteric ABS Deal of the Year by GlobalCapital. Leah also advises on novel IP securitizations related to musical composition, sound recording copyrights, television and other royalties. Most recently, Leah represented the investors in the groundbreaking securitization by Syco Entertainment of intellectual property in the “Got Talent” franchise.

Leah’s experience further extends to a wide variety of other esoteric assets, including tax liens, diamond receivables, participations, tax credits, solar and wind ground leases and whole business operating company securitizations.

Recognized in Band 1 of Chambers USA Nationwide Securitization: PACE, Leah is described by clients as “one of the best lawyers that I have worked with” and someone who “fights tooth and nail for her clients.” Resources for the Legal 500 USA directory have called Leah “the best there is in esoteric financing products and bonds,” and note they are “incredibly impressed with the gender diversity on the team. Extremely ethical – name carries a lot of weight with investors.”

740

Practice:

  • Finance Sector
  • Structured Finance
  • Asset‐Backed Securities
  • Derivatives
  • スワップなどのヘッジ手段
  • Fintech

Al Sawyers パートナー

New York

Al represents issuers and underwriters in the issuance of credit-linked notes, collateralized bond obligations, synthetic convertible bonds and synthetic money market eligible securities. He also works with clients entering into various swap agreements, such as interest rate, credit default, currency, and equity swaps, and has authored alerts on various financial industry-related topics, including the Dodd-Frank Act.

Al has been ranked by Chambers and Partners both globally and nationally in the structured products category. Legal500 has noted Al for his work in structured finance, quoting a client who stated that he has "impressive expertise in all facets of securitization in general, which is immensely helpful when we are working on complex transactions." The International Financial Law Review has also recognized Al for his work in structured finance and securitization. Euromoney notes him as an expert in Banking, Financial and Transactional Law: Structured Finance and Securitization.

417472

Practice:

  • Banking & Finance
  • Private Credit

Andrew Schmidt アソシエイト

New York

Drew is a managing associate in Orrick’s New York office and a member of the Banking and Finance group.  He advises funds, investment advisors, sponsors and corporate borrowers on the full spectrum of financings, including direct lending transactions, first lien-second lien facilities, superpriority revolvers, recurring revenue loans, refinancings, hybrid debt-equity instruments and other bespoke structures. Drew represents clients from the origination of the deal to repayment, conversion or satisfaction, and he has hands-on experience with enforcement actions and remedies. 

Practice:

  • Capital Markets
  • 企業ガバナンス
  • Mergers and Acquisitions

David Schwartz パートナー

New York

David is recognized as a trusted advisor who delivers valued execution and results.

  • Thomson Reuters has recognized David as a Stand-out Lawyer.
  • BTI Consulting has ranked David as a Client Service All Star.
  • Chambers has ranked David for his M&A work, with clients noting he is “on top of cutting-edge trends and ideas", "proactive, engaged and personable", and possesses a “depth of legal expertise” and “creative solutions to thorny problems” that “make him our go-to."
  • Legal500 has ranked David as a Leading Partner for M&A. He has also been featured in Legal500's US M&A Powerlist, with clients noting he "is an incredible relationship partner. His dedication to understanding our business and our ways of working is complimented by his proactive approach to providing innovative solutions and ideas."